Compare

Gain Therapeutics, Inc. vs Faeth Therapeutics, Inc. vs BriaCell Therapeutics Corp. vs Immunic, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Gain Therapeutics, Inc. GANX	Faeth Therapeutics, Inc. FTH	BriaCell Therapeutics Corp. BCTX	Immunic, Inc. IMUX
Year ended	2025-12-31	2025-12-31	2025-07-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$20.16M	-$21.09M	-$26.31M	-$97.17M
EPS (Diluted)	-$0.61	-$16.72	-$62.19	-$0.62
Operating cash flow	-$18.47M	-$20.45M	-$28.17M	-$85.81M
Free cash flow	n/a	-$20.47M	n/a	-$85.97M
Cash & equivalents	$20.84M	$8.67M	$10.49M	$15.48M
Total assets	$22.82M	$22.90M	$21.65M	$24.05M
Total liabilities	$4.25M	$4.31M	n/a	$30.73M
Shareholders' equity	$18.56M	$18.59M	$17.33M	-$6.67M
Return on year-end equity	-108.6%	-113.4%	-151.8%	n/a
Shares outstanding	42.07M	1.26M	1.88M	90.15M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Gain Therapeutics, Inc.	Faeth Therapeutics, Inc.	BriaCell Therapeutics Corp.	Immunic, Inc.
Latest	$55.2K Ended 2023-12-31	n/a	n/a	n/a
1 year earlier	$140.1K Ended 2022-12-31	n/a	n/a	n/a
2 years earlier	$165.0K Ended 2021-12-31	n/a	n/a	n/a
3 years earlier	$28.9K Ended 2020-12-31	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a